(Q86700388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

NAFLD. Accurate quantification of hepatic fat--is it important? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Leon A Adams

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

10 February 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

126-127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrgastro.2015.23

29 February 2020

exact match

0 references

cites work

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Endpoints and clinical trial design for nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2015.23

31 March 2020

Identifiers

DOI

10.1038/NRGASTRO.2015.23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25666645%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference